🔎 Trials Near Me

Utama › Kanser Ovari › Kentucky

Kajian klinikal Kanser Ovari di Kentucky

25 kajian untuk Kanser Ovari sedang mencari peserta di lokasi di Kentucky.

Bandar di Kentucky

Teks kajian rasmi (Bahasa Inggeris)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
  • University of Kentucky/Markey Cancer Center, Lexington
Mengambil pesertaFasa 2
Semua umur · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05564377

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

  • Site 0251 - Norton Cancer Institute, Louisville
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 29 Sep 2026 · NCT05128825

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • Baptist Health Lexington /ID# 275218, Lexington
  • Norton Cancer Institute - St. Matthews /ID# 276173, Louisville
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 29 Sep 2026 · NCT06890338

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

  • Baptist Health Lexington /ID# 278267, Lexington
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 22 Sep 2026 · NCT07059845

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Baptist Health Lexington, Lexington
  • Norton Women's and Children's Hospital, Louisville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07213804

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Norton Cancer Institute, Louisville
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05983432

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • Norton Cancer Institute, Louisville
Mengambil pesertaFasa 2
Umur 18 hingga 99 · Wanita · Dikemas kini 15 Sep 2026 · NCT07023627

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • St Elizabeth Healthcare, Edgewood
Mengambil pesertaFasa 3
Umur 18 ke atas · Wanita · Dikemas kini 15 Sep 2026 · NCT07214779

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

  • Norton Cancer Institute Research, Louisville
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06303505

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

  • Norton Cancer Institute, St. Matthews Clinic, Louisville
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 14 Sep 2026 · NCT06787612

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • St. Elizabeth Healthcare, Edgewood
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT06774963

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  • University of Kentucky/Markey Cancer Center, Lexington
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT07001748

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • Baptist Health Corbin, Corbin
  • Baptist Health Lexington, Lexington
  • Norton Hospital Pavilion and Medical Campus, Louisville
  • dan 5 lagi
Mengambil peserta
Umur 35 hingga 50 · Wanita · Dikemas kini 7 Ogo 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
  • Baptist Health Corbin, Corbin
  • Commonwealth Cancer Center-Corbin, Corbin
  • dan 10 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06580314

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • St. Elizabeth Medical Center, Edgewood
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Jul 2026 · NCT06161025

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • University of Kentucky, Lexington
Mengambil pesertaFasa 1/2
Umur 18 hingga 90 · Semua jantina · Dikemas kini 6 Jul 2026 · NCT06710756

EXoPERT EMERALD Clinical Study

  • Lexington VA Healthcare System, Lexington
  • KCTL, Louisville
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 45 ke atas · Semua jantina · Dikemas kini 1 Jul 2026 · NCT07186296

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

  • St. Elizabeth Medical Center - Edgewood /ID# 272113, Edgewood
  • Baptist Health Lexington /ID# 272211, Lexington
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 26 Mei 2026 · NCT06682988

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

  • University of Kentucky Medical Center, Lexington
Mengambil pesertaFasa 3
Umur 18 ke atas · Wanita · Dikemas kini 16 Apr 2026 · NCT05659381

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

  • University of Kentucky, Lexington
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Apr 2026 · NCT04779554

Combination Therapy for Recurrent Ovarian Cancer

  • UofL Health Brown Cancer Center, Louisville
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Wanita · Dikemas kini 19 Mac 2026 · NCT05610735

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  • University of Kentucky Markey Cancer Center, Lexington
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Feb 2026 · NCT06778863

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

  • University of Kentucky Medical Center, Lexington
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Feb 2026 · NCT05103683

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Baptist Corbin, Corbin
  • Baptist Hardin, Elizabethtown
  • Baptist Lexington, Lexington
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 ke atas · Semua jantina · Dikemas kini 20 Jan 2026 · NCT05366881

Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer

  • Markey Cancer Center, Lexington
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 24 ke atas · Wanita · Dikemas kini 14 Nov 2025 · NCT04473833

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.